- Report
- January 2026
- 194 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- January 2026
- 194 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- January 2026
- 188 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- January 2026
- 182 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- January 2026
- 180 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- April 2025
Global
From €4423EUR$4,900USD£3,831GBP
- Report
- March 2026
- 371 Pages
Global
From €5280EUR$5,850USD£4,574GBP
- Report
- March 2026
- 280 Pages
Global
From €5280EUR$5,850USD£4,574GBP
- Report
- March 2026
- 379 Pages
Global
From €5280EUR$5,850USD£4,574GBP
- Report
- January 2026
- 181 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- August 2025
- 188 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- January 2026
- 191 Pages
Global
From €3200EUR$3,545USD£2,772GBP
€3555EUR$3,939USD£3,080GBP
- Report
- April 2025
- 182 Pages
Global
From €4062EUR$4,500USD£3,519GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1354EUR$1,500USD£1,173GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Report
- February 2026
- 250 Pages
Global
From €4053EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4053EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4053EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4053EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4053EUR$4,490USD£3,511GBP
![Loading Indicator](/images/loading.gif")
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more
![Logo 91¿´Æ¬](/images/logo.svg"){kind=logo}
![Logo 91¿´Æ¬](/images/logo-research-and-markets-print.png"){kind=logo}